An unmet need exists for high molecular weight HA that can be produced from a safe, non-animal source at economical cost.

HA-based products generated over $2.25 billion in sales in the United States in 2006.

This included ophthalmic applications as well as visco-supplementation, visco-surgical aid, cosmetic injection, and anti-adhesive wound care applications.